Company Filing History:
Years Active: 2019-2022
Title: Rob Righi: Innovating in Medical Catheter Technology
Introduction: Rob Righi, a prolific inventor based in Chandler, AZ, has made significant contributions to the field of medical technology. With four patents to his name, he focuses on innovations that enhance the efficacy and safety of vascular treatments. His work is instrumental in developing solutions that improve patient outcomes during medical procedures.
Latest Patents: Among Rob's latest patents is the "Balloon Catheter with Transient Radiopaque Marking." This innovation involves a catheter designed for positioning at a treatment area in the vasculature. It features a first balloon that includes a transient radiopaque material, allowing for precise treatment area visualization. Alongside this is the "Balloon Catheter with Enhanced Locatability," which incorporates markings along the catheter's shaft. These markings help measure distances within the vessel and ensure the proper positioning of the balloon relative to the treatment area, enhancing overall treatment effectiveness.
Career Highlights: Rob Righi is associated with Clearstream Technologies Limited, where he focuses on advancing catheter technology. His role allows him to collaborate with others in the field and contribute to research that pushes the boundaries of current medical practices.
Collaborations: Throughout his career, Rob has worked alongside talented professionals such as Stephanie Klocke and Jim C Beasley. Their collective expertise and innovative mindset foster an environment of collaboration, driving forward the development of groundbreaking medical technologies.
Conclusion: Rob Righi embodies the spirit of innovation in the medical field. With a strong focus on creating effective solutions for vascular treatments, his patents reflect a commitment to improving patient care. As technology continues to evolve, inventors like Rob will be at the forefront of these advancements, making healthcare safer and more efficient for everyone.